Webinar: Equity Compensation in University Startups

Equity compensation can be an opaque and awkward topic for first-time academic founders. Join us for a webinar that is an in-depth look at venture capital perspectives on the economics of university startup formation, particularly founders’ equity. OUP will review an analysis of the equity structures of over 90 startups combined with our collective insights…

Webinar: Startup Licensing 101 – Term Sheets & Financials

For many entrepreneurs, licensing from a university may be a new experience. This series of webinars provides information that will be helpful for academic entrepreneurs contemplating their first (or perhaps subsequent) license from an academic institution. Presented by an attorney who represents many academic startups, including their investors, along with two academic technology transfer veterans, these webinars bring views from both sides of the table and best practices for a fruitful and efficient negotiation.

Webinar: Startup Licensing 101 – The 30,000 Foot View

This is part 1 of a 5-part webinar series called Startup Licensing 101: A Resource for Entrepreneurs Working with Companies Originated at Academic Institutions.

For many entrepreneurs, licensing from a university may be a new experience. This series of webinars provides information that will be helpful for academic entrepreneurs contemplating their first (or perhaps subsequent) license from an academic institution. Presented by an attorney who represents many academic startups, including their investors, along with two academic technology transfer veterans, these webinars bring views from both sides of the table and best practices for a fruitful and efficient negotiation.

Webinar: Small Molecule vs Antibody Development Challenges

Therapeutics remain the primary focus for life science venture investments. As we all know, pre-clinical development of therapeutics is complicated, time consuming, and capital intensive. In the early stages of development, multiple aspects of a therapeutic product need to be optimized to enhance its drug-like properties. However, given the limited time and resources in the academic setting, what aspects of development should inventors focus on? Before diving into drug development, inventors should ask themselves: What is feasible in an academic setting? What is valued more by the investors? Should it be performed in-house or be out-sourced? How much would it cost?

Webinar: How VCs Evaluate CEOs

Columbia Technology Ventures (CTV) and venture investors Osage University Partners (OUP) invite you to view a seminar on the following topic: “The behind-the-scenes view on how VCs evaluate potential startup CEOS.”

Drawing from 25 years of venture capital experience, Osage University Partners (OUP) managing partner Marc Singer will take you through the CEO search process, how VCs evaluate potential entrepreneur, and some observations about drivers for long-term success as an entrepreneur. The audience will assess mock candidate profiles and learn methods of diligence to choose the right leader for your startup.

Webinar: Understanding Equity Economics as the Startup Grows

Columbia Technology Ventures (CTV) and venture investors Osage University Partners (OUP) invite you to join a seminar on the following topic: “Understanding the real economics of university startup formation.”

OUP principal John Lee will take you step-by-step through the life of a company, illustrating the different types equity, the pros and cons of each equity type depending on different company outcomes, and the economic effect this has on founders’ shares. Data will be presented to support the conversation around founders’ equity, the right allocation between faculty vs. post docs vs. grad students, and how much equity one needs to give away to attract and keep your top talent.

Webinar: University Innovation Pitching

This workshop will focus on teaching you how to help investigators focus their technology disclosures, funding pitches, and other presentations on the three key factors crucial to gaining interest and commitment: commercial potential, technical merit and investigator willingness to assist.